Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRZO
2476
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $686K | ﹤0.01% |
22,448
+1,444
| +7% | +$52.3K |
|
|
SCHW
2477
Charles Schwab
SCHW
$194B
| $685K | ﹤0.01% |
+23,988
| New | +$770K |
|
|
ANCX
2478
DELISTED
Access National Corp
ANCX
| $684K | ﹤0.01% |
+33,567
| New | +$669K |
|
2479
Lockheed Martin
LMT
$128B
| $682K | ﹤0.01% |
3,292
-80,465
| -96% | -$16.4M |
|
2480
Comstock Resources
CRK
$4.16B
| $681K | ﹤0.01% |
71,277
+21,244
| +42% | +$236K |
|
2481
Banco Macro
BMA
$4.97B
| $680K | ﹤0.01% |
17,696
-2,827
| -14% | -$127K |
|
|
DSPG
2482
DELISTED
DSP Group Inc
DSPG
| $679K | ﹤0.01% |
74,567
+20,874
| +39% | +$186K |
|
|
CTWS
2483
DELISTED
Connecticut Water Service Inc
CTWS
| $678K | ﹤0.01% |
18,572
+12,431
| +202% | +$433K |
|
2484
Aldeyra Therapeutics
ALDX
$93.5M
| $677K | ﹤0.01% |
116,100
-2,900
| -2% | -$22.6K |
|
2485
Spok Holdings
SPOK
$221M
| $677K | ﹤0.01% |
41,101
+16,326
| +66% | +$270K |
|
2486
VanEck Biotech ETF
BBH
$474M
| $676K | ﹤0.01% |
+5,914
| New | +$783K |
|
2487
Bassett Furniture
BSET
$164M
| $675K | ﹤0.01% |
+24,236
| New | +$779K |
|
|
RAS
2488
DELISTED
RAIT Financial Trust
RAS
| $675K | ﹤0.01% |
136,110
+107,972
| +384% | +$592K |
|
2489
Lifecore Biomedical
LFCR
$176M
| $673K | ﹤0.01% |
57,670
+24,447
| +74% | +$324K |
|
2490
PUT
Five Below
FIVE
$14.3B
| $672K | ﹤0.01% |
+20,000
| New | +$727K |
|
2491
McEwen Inc
MUX
$1.32B
| $672K | ﹤0.01% |
76,862
-21,905
| -22% | -$181K |
|
|
FPI
2492
Farmland Partners
FPI
$448M
| $671K | ﹤0.01% |
+63,951
| New | +$688K |
|
2493
Goldgroup Mining
GORO
$292M
| $671K | ﹤0.01% |
265,320
-104,832
| -28% | -$250K |
|
2494
CALL
NRG Energy
NRG
$23.9B
| $668K | ﹤0.01% |
+45,000
| New | +$894K |
|
|
BNK
2495
DELISTED
C1 FINL INC COM STK (FL)
BNK
| $664K | ﹤0.01% |
34,833
+15,729
| +82% | +$297K |
|
2496
FirstCash
FCFS
$9.95B
| $663K | ﹤0.01% |
16,546
-24,636
| -60% | -$1.01M |
|
|
FGL
2497
DELISTED
Fidelity & Guaranty Life
FGL
| $663K | ﹤0.01% |
27,026
-95,498
| -78% | -$2.37M |
|
|
ENOC
2498
DELISTED
EnerNOC, Inc.
ENOC
| $662K | ﹤0.01% |
+83,781
| New | +$728K |
|
|
RELY
2499
DELISTED
Real Industry, Inc.
RELY
| $662K | ﹤0.01% |
75,037
+9,163
| +14% | +$97.4K |
|
|
ADVM
2500
DELISTED
Adverum Biotechnologies
ADVM
| $659K | ﹤0.01% |
8,000
-90,488
| -92% | -$11.6M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.